Nestor F. Esnaola

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Maen Abdelrahim · 2 shared papers, 2024–2026 · strength 0.47
   • Paper Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail. DOI 10.1038/s41698-024-00571-4↗
   • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
2. Abdullah Esmail · 1 shared paper, 2024 · strength 0.24
   • Paper Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail. DOI 10.1038/s41698-024-00571-4↗
3. Anup Kasi · 1 shared paper, 2024 · strength 0.24
   • Paper Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail. DOI 10.1038/s41698-024-00571-4↗
4. Benjamin Adam Weinberg · 1 shared paper, 2024 · strength 0.24
   • Paper Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail. DOI 10.1038/s41698-024-00571-4↗
5. Kelvin Allenson · 1 shared paper, 2026 · strength 0.23
   • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
6. Ashish Saharia · 1 shared paper, 2026 · strength 0.23
   • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
7. Ahmed Elaileh · 1 shared paper, 2026 · strength 0.23
   • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
8. Ahmed Osama Gaber · 1 shared paper, 2026 · strength 0.23
   • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
9. Ashton Anthony Connor · 1 shared paper, 2026 · strength 0.23
   • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
10. Kirk Heyne · 1 shared paper, 2026 · strength 0.23
    • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
11. Youssef E. Dib · 1 shared paper, 2026 · strength 0.23
    • Paper Neoadjuvant Therapy and Pancreatic Cancer Resection Outcomes: A Retrospective Analysis at a Quaternary Care Center. DOI 10.1016/j.jss.2026.02.012↗
12. David J. Cole · 1 shared paper, 2014 · strength 0.04
    • Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030↗
13. Ernest Ramsay Camp · 1 shared paper, 2014 · strength 0.04
    • Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030↗
14. David T. Marshall · 1 shared paper, 2014 · strength 0.04
    • Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030↗
15. Alberto J. Montero · 1 shared paper, 2014 · strength 0.04
    • Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030↗
16. Paul E. O’Brien · 1 shared paper, 2014 · strength 0.04
    • Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.